CCL2 and cancer: In monocytes and macrophages, cancer EVs can activate Toll-like receptor-mediated signaling cascade, triggering NFκB- and STAT3-mediated production of proinflammatory cytokines – IL-6, IL-8, IL-1β, CCL2, G-CSF, and TNF-α (104, 105).